On Oct. 9, 2026, Teva Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved WELTRUZA™ (olanzapine)…
On Sept. 1, 2026, Massachusetts Institute of Technology (MIT) researchers release a study that reveals insights into populations…
On Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…
On Mar. 12, 2026, the Stanley Family Foundation renewed its commitment to psychiatric research at the Broad Institute,…
On Sept. 26, 2024, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb’s Cobenfy (xanomeline and trospium…
On Aug. 30, 2024, the California Institute for Regenerative Medicine (CIRM) approved $67.5 million to support five projects…
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
On Dec. 29, 1993, the U.S. Food and Drug Administration (FDA) approved indications for oral risperidone (tablets, oral…
In 1980, autism appeared for the first time as a diagnosis in the third edition of the DSM…
In 1952, the first edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) was published and…
On Apr. 24, 1908, Swiss psychiatrist Eugen Bleuler coined the term ‘schizophrenia’ at a lecture at a meeting…